We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Help improve GOV.UK Sign up to take part in user research (opens in a new tab)
Infected Blood Compensation Authority's update that was circulated on 9 July
Hello, and welcome to your community update. This week marks one year…
The MHRA is urging people to “summer-proof your health” as warmer weather, travel, and changing routines can affect how medicines and medical devices work, with simple steps to help prevent avoidable harm.
Medicines and Healthcare products Regulatory Agency (MHRA) has approved the use of UK‑donor plasma for five high‑priority plasma-derived medicinal products.
Amber heat-health alerts are now in place across all regions of England except the North East, which remains under a yellow alert.
Life Sciences sector attracts over £3 billion in new public-private investment in 12 months, reflecting international confidence in UK science and innovation.
The MHRA’s Criminal Enforcement Unit dismantled a multimillion-pound criminal network responsible for illegally supplying medicines.
The Parliamentary Under-Secretary of State writes to the chair of the Food Standards Agency to confirm agreed economic growth goals.
As with any medicinal product, the MHRA will keep the safety and effectiveness of nerandomilast under close review.
Government announces 10 Year Capital Plan to modernise NHS buildings, upgrade GP surgeries and bring more care closer to patients’ homes.
National framework launched to help reduce premature deaths from heart disease and strokes by a quarter over the next decade.
New NHS staff standards will make employers accountable for tackling racism, violence and sexual harassment, with results published in league tables.
Merkel cell carcinoma (MCC) is a rare and aggressive type of skin cancer that develops from Merkel cells, specialised neuroendocrine cells found in the top layer of the skin.
The semaglutide injection has been approved to treat metabolic-associated steatohepatitis (MASH) in adults with moderate-to-advanced liver fibrosis.
NHS patients could access cutting-edge medicines potentially months earlier under a series of pioneering pilot schemes.
MHRA CEO argues that for the UK’s long-term health and prosperity, regulation should help lead, rather than follow, innovation
The Food Standards Agency has published the results of its sixth annual retail surveillance survey.
As with any medicinal product, the MHRA will keep the safety and effectiveness of the intravesical delivery system containing gemcitabine under close review.
MHRA investigation secures fraud convictions linked to the supply of non-compliant medical devices.
Information on the expansion of the eligibility criteria of the older adults respiratory syncytial virus (RSV) vaccination programme from 1 September 2026.
New commissioner and extra funding announced to make maternity and neonatal care safer, fairer and more consistent across England.
Do not include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).